Atsushi Aruga

1.9k total citations
64 papers, 1.4k citations indexed

About

Atsushi Aruga is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Atsushi Aruga has authored 64 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 34 papers in Oncology and 17 papers in Molecular Biology. Recurrent topics in Atsushi Aruga's work include Immunotherapy and Immune Responses (34 papers), Cancer Immunotherapy and Biomarkers (18 papers) and CAR-T cell therapy research (14 papers). Atsushi Aruga is often cited by papers focused on Immunotherapy and Immune Responses (34 papers), Cancer Immunotherapy and Biomarkers (18 papers) and CAR-T cell therapy research (14 papers). Atsushi Aruga collaborates with scholars based in Japan, United States and Pakistan. Atsushi Aruga's co-authors include Alfred E. Chang, Masakazu Yamamoto, Mark J. Cameron, E Aruga, Ken Takasaki, Yoshihito Kotera, D. Keith Bishop, Nobuhiro Takeshita, Ryuji Okuyama and Vernon K. Sondak and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Atsushi Aruga

60 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Atsushi Aruga Japan 22 889 782 440 255 189 64 1.4k
Norman Woller Germany 20 595 0.7× 886 1.1× 467 1.1× 114 0.4× 472 2.5× 36 1.5k
Naotake Tsuda Japan 21 577 0.6× 526 0.7× 621 1.4× 87 0.3× 115 0.6× 66 1.3k
Satoko Matsueda Japan 24 1.2k 1.3× 935 1.2× 713 1.6× 189 0.7× 55 0.3× 85 1.8k
Nikolaos Svoronos United States 17 784 0.9× 806 1.0× 707 1.6× 90 0.4× 159 0.8× 21 1.6k
Grégory Verdeil Switzerland 22 1.2k 1.4× 957 1.2× 409 0.9× 168 0.7× 65 0.3× 40 1.8k
Jennifer N. Durham United States 18 400 0.4× 649 0.8× 379 0.9× 75 0.3× 139 0.7× 53 1.2k
Peter R. Rhode United States 22 1.1k 1.2× 853 1.1× 491 1.1× 173 0.7× 111 0.6× 57 2.0k
Yuichiro Hamanaka Japan 16 319 0.4× 559 0.7× 389 0.9× 303 1.2× 76 0.4× 39 1.2k
Takayuki Ohkuri Japan 22 1.5k 1.6× 976 1.2× 583 1.3× 59 0.2× 87 0.5× 56 2.0k
Friedrich H. Schmitz-Winnenthal Germany 12 271 0.3× 604 0.8× 211 0.5× 208 0.8× 106 0.6× 22 953

Countries citing papers authored by Atsushi Aruga

Since Specialization
Citations

This map shows the geographic impact of Atsushi Aruga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsushi Aruga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsushi Aruga more than expected).

Fields of papers citing papers by Atsushi Aruga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsushi Aruga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsushi Aruga. The network helps show where Atsushi Aruga may publish in the future.

Co-authorship network of co-authors of Atsushi Aruga

This figure shows the co-authorship network connecting the top 25 collaborators of Atsushi Aruga. A scholar is included among the top collaborators of Atsushi Aruga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsushi Aruga. Atsushi Aruga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Matsushita, Norimasa, Shiho Yamamoto, Yuji Inoue, Atsushi Aruga, & Masakazu Yamamoto. (2017). RT-qPCR analysis of the tumor antigens TOMM34 and RNF43 in samples extracted from paraffin-embedded specimens of colorectal cancer. Oncology Letters. 14(2). 2281–2287. 9 indexed citations
3.
Watanabe, Natsumi, et al.. (2016). Compassionate use of drugs and medical devices in the United States, the European Union and Japan. Regenerative Therapy. 4. 18–26. 17 indexed citations
4.
Kobayashi, Yasunobu, Yusuke Ito, Valentina V. Ostapenko, et al.. (2014). Fever-range whole-body heat treatment stimulates antigen-specific T-cell responses in humans. Immunology Letters. 162(1). 256–261. 16 indexed citations
5.
Aruga, Atsushi, et al.. (2014). Approval Status and Regulatory Actions for Radiopharmaceuticals in the United States and Japan. Therapeutic Innovation & Regulatory Science. 48(5). 635–643. 1 indexed citations
6.
Shimizu, Koïchi, Yoshihito Kotera, Atsushi Aruga, et al.. (2014). Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma. Human Vaccines & Immunotherapeutics. 10(4). 970–976. 46 indexed citations
7.
Aruga, Atsushi, Nobuhiro Takeshita, Yoshihito Kotera, et al.. (2013). Long-term Vaccination with Multiple Peptides Derived from Cancer-Testis Antigens Can Maintain a Specific T-cell Response and Achieve Disease Stability in Advanced Biliary Tract Cancer. Clinical Cancer Research. 19(8). 2224–2231. 56 indexed citations
8.
Aruga, Atsushi. (2013). Vaccination of biliary tract cancer patients with four peptides derived from cancer-testis antigens. OncoImmunology. 2(7). e24882–e24882. 3 indexed citations
9.
Matsushita, Norimasa, Atsushi Aruga, Yuji Inoue, et al.. (2013). Phase I clinical trial of a peptide vaccine combined with tegafur-uracil plus leucovorin for treatment of advanced or recurrent colorectal cancer. Oncology Reports. 29(3). 951–959. 22 indexed citations
10.
Okuyama, Ryuji, Atsushi Aruga, Takashi Hatori, Kazuyoshi Takeda, & Masakazu Yamamoto. (2013). Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patients. OncoImmunology. 2(11). e27010–e27010. 46 indexed citations
11.
Aruga, Atsushi, et al.. (2013). Immunological monitoring of anticancer vaccines in clinical trials. OncoImmunology. 2(8). e26012–e26012. 34 indexed citations
12.
Yamamoto, Masakazu, et al.. (2004). Immunohistological evaluation of single small hepatocellular carcinoma with negative staining of monoclonal antibody Hepatocyte Paraffin 1. Journal of Surgical Oncology. 88(2). 104–107. 11 indexed citations
13.
Takasaki, Ken, Masakazu Yamamoto, Atsushi Aruga, et al.. (2000). Clinicopathological Significance of Alpha-fetoprotein and PIVKA-II Measurement in Operated Patients with Hepatocellular Carcinoma.. The Japanese Journal of Gastroenterological Surgery. 33(1). 25–31. 1 indexed citations
14.
Aruga, E, Atsushi Aruga, Hiroshi Arai, et al.. (2000). CD95-Mediated Tumor Recognition by CD4+ Effector Cells in a Murine Mammary Model. Journal of Immunotherapy. 23(2). 225–234. 6 indexed citations
15.
16.
Aruga, Atsushi, et al.. (1997). Cytokines as an adjuvant to tumor vaccines: Efficacy of local methods of delivery. Annals of Surgical Oncology. 4(7). 579–585. 12 indexed citations
17.
Chang, Alfred E., Atsushi Aruga, Mark J. Cameron, et al.. (1997). Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2.. Journal of Clinical Oncology. 15(2). 796–807. 120 indexed citations
18.
Arca, Marjorie J., John C. Krauss, Atsushi Aruga, Mark J. Cameron, & Alfred E. Chang. (1997). Concurrent Induction of CD4+ and CD8+ T Cells During Tumor Growth with Antitumor Reactivity in Adoptive Immunotherapy. Journal of Immunotherapy. 20(2). 138–145. 11 indexed citations
19.
Suzuki, Takafumi, Ken Takasaki, Atsushi Aruga, et al.. (1991). Hepatic encephalopathy due to a porto-systemic shunt with reverse circulation in the portal tract. A case report.. Kanzo. 32(7). 730–734. 3 indexed citations
20.
Otsubo, Takehito, Ken Takasaki, Masakazu Yamamoto, et al.. (1990). Two resected cases of hepatoma with liver cirrhosis and porto-caval shunt, after closing the shunt.. Kanzo. 31(3). 342–345. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Norman Woller Breakdown of academic impact, for papers by Naotake Tsuda Breakdown of academic impact, for papers by Satoko Matsueda Breakdown of academic impact, for papers by Nikolaos Svoronos Breakdown of academic impact, for papers by Grégory Verdeil Breakdown of academic impact, for papers by Jennifer N. Durham Breakdown of academic impact, for papers by Peter R. Rhode Breakdown of academic impact, for papers by Yuichiro Hamanaka Breakdown of academic impact, for papers by Takayuki Ohkuri Breakdown of academic impact, for papers by Friedrich H. Schmitz-Winnenthal
Rankless by CCL
2026